Portolan Capital Management - SYROS PHARMACEUTICALS INC ownership

SYROS PHARMACEUTICALS INC's ticker is SYRS and the CUSIP is 87184Q107. A total of 107 filers reported holding SYROS PHARMACEUTICALS INC in Q1 2021. The put-call ratio across all filers is 1.79 and the average weighting 0.1%.

Quarter-by-quarter ownership
Portolan Capital Management ownership history of SYROS PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2020$4,144,000
+4.0%
381,919
-15.3%
0.38%
-16.4%
Q3 2020$3,986,000
-25.0%
450,861
-9.6%
0.45%
-25.7%
Q2 2020$5,316,000
+74.9%
498,666
-2.7%
0.61%
+33.1%
Q1 2020$3,040,000
+34.6%
512,570
+56.8%
0.46%
+100.0%
Q4 2019$2,259,000326,8470.23%
Other shareholders

There were no reported owners of SYROS PHARMACEUTICALS INC in Q1 2021.

NameSharesValueWeighting ↓
View complete list of SYROS PHARMACEUTICALS INC shareholders